These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

620 related articles for article (PubMed ID: 26599199)

  • 1. Potential risks associated with traditional herbal medicine use in cancer care: A study of Middle Eastern oncology health care professionals.
    Ben-Arye E; Samuels N; Goldstein LH; Mutafoglu K; Omran S; Schiff E; Charalambous H; Dweikat T; Ghrayeb I; Bar-Sela G; Turker I; Hassan A; Hassan E; Saad B; Nimri O; Kebudi R; Silbermann M
    Cancer; 2016 Feb; 122(4):598-610. PubMed ID: 26599199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complementary and alternative medicine use among cancer patients in Palestine with special reference to safety-related concerns.
    Ali-Shtayeh MS; Jamous RM; Salameh NM; Jamous RM; Hamadeh AM
    J Ethnopharmacol; 2016 Jul; 187():104-22. PubMed ID: 27125594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Communication and integration: a qualitative analysis of perspectives among Middle Eastern oncology healthcare professionals on the integration of complementary medicine in supportive cancer care.
    Ben-Arye E; Popper-Giveon A; Samuels N; Mutafoglu K; Schiff E; Omran S; Charalambous H; Dweikat T; Ghrayeb I; Turker I; Hassan A; Hassan E; Nimri O; Kebudi R; Silbermann M
    J Cancer Res Clin Oncol; 2016 May; 142(5):1117-26. PubMed ID: 26833203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Herbal medicines safety concerns in patients with cancer.
    Bagcchi S
    Lancet Oncol; 2016 Jan; 17(1):e10. PubMed ID: 26670091
    [No Abstract]   [Full Text] [Related]  

  • 5. Herbal use amongst multiethnic medical patients in Penang Hospital: pattern and perceptions.
    Saw JT; Bahari MB; Ang HH; Lim YH
    Med J Malaysia; 2006 Oct; 61(4):422-32. PubMed ID: 17243519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bridging cross-cultural gaps: monitoring herbal use during chemotherapy in patients referred to integrative medicine consultation in Israel.
    Almog L; Lev E; Schiff E; Linn S; Ben-Arye E
    Support Care Cancer; 2014 Oct; 22(10):2793-804. PubMed ID: 24817575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety of herbal medicine use during chemotherapy in patients with ovarian cancer: a "bedside-to-bench" approach.
    Ben-Arye E; Lavie O; Samuels N; Khamaisie H; Schiff E; Raz OG; Mahajna J
    Med Oncol; 2017 Apr; 34(4):54. PubMed ID: 28238155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploring an herbal "wonder cure" for cancer: a multidisciplinary approach.
    Ben-Arye E; Mahajna J; Aly R; Ali-Shtayeh MS; Bentur Y; Lev E; Deng G; Samuels N
    J Cancer Res Clin Oncol; 2016 Jul; 142(7):1499-508. PubMed ID: 27155666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences between herbal and nonherbal users in dental practice.
    Tam KK; Gadbury-Amyot CC; Cobb CM; Williams KB
    J Dent Hyg; 2006; 80(1):10. PubMed ID: 16451764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An assessment of the impact of herb-drug combinations used by cancer patients.
    Alsanad SM; Howard RL; Williamson EM
    BMC Complement Altern Med; 2016 Oct; 16(1):393. PubMed ID: 27756298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Herbal supplement use by persons aged over 50 years in Britain: frequently used herbs, concomitant use of herbs, nutritional supplements and prescription drugs, rate of informing doctors and potential for negative interactions.
    Canter PH; Ernst E
    Drugs Aging; 2004; 21(9):597-605. PubMed ID: 15260514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Herbal remedies in the United States: potential adverse interactions with anticancer agents.
    Sparreboom A; Cox MC; Acharya MR; Figg WD
    J Clin Oncol; 2004 Jun; 22(12):2489-503. PubMed ID: 15197212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HERBAL PRODUCT USE BY THE CANCER PATIENTS IN BOTH THE PRE AND POST SURGERY PERIODS AND DURING CHEMOTHERAPY.
    Koçaşlı S; Demircan Z
    Afr J Tradit Complement Altern Med; 2017; 14(2):325-333. PubMed ID: 28573249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence-based management of herb-drug interaction in cancer chemotherapy.
    Cheng CW; Fan W; Ko SG; Song L; Bian ZX
    Explore (NY); 2010; 6(5):324-9. PubMed ID: 20832765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prevalence of usage of herbal medicines among cancer patients.
    Tuna S; Dizdar O; Calis M
    J BUON; 2013; 18(4):1048-51. PubMed ID: 24344037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Who's talking? Communication between health providers and HIV-infected adults related to herbal medicine for AIDS treatment in western Uganda.
    Langlois-Klassen D; Kipp W; Rubaale T
    Soc Sci Med; 2008 Jul; 67(1):165-76. PubMed ID: 18406030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Herbal product use by older adults.
    González-Stuart A
    Maturitas; 2011 Jan; 68(1):52-5. PubMed ID: 20970932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medical residents' and students' attitudes towards herbal medicines: a pilot study.
    Xu S; Levine M
    Can J Clin Pharmacol; 2008; 15(1):e1-4. PubMed ID: 18184982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Herb use among health care professionals enrolled in an online curriculum on herbs and dietary supplements.
    Gardiner P; Legedza A; Woods C; Phillips RS; Kemper KJ
    J Herb Pharmacother; 2006; 6(2):51-64. PubMed ID: 17182485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A gap between acceptance and knowledge of herbal remedies by physicians: the need for educational intervention.
    Clement YN; Williams AF; Khan K; Bernard T; Bhola S; Fortuné M; Medupe O; Nagee K; Seaforth CE
    BMC Complement Altern Med; 2005 Nov; 5():20. PubMed ID: 16297236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.